Literature DB >> 21001625

Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).

A B CARLETON, R A PETERS.   

Abstract

Entities:  

Keywords:  ARSENIC/toxicity; MERCAPTOPROPANOL/therapy; SYPHILIS/therapy

Mesh:

Substances:

Year:  1946        PMID: 21001625      PMCID: PMC435589          DOI: 10.1172/jci101733

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  The iodometric micro-determination of arsenic in biological material.

Authors:  G A Levvy
Journal:  Biochem J       Date:  1943       Impact factor: 3.857

2.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL.

Authors:  W T Longcope; J A Luetscher; M M Wintrobe; V Jäger
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

3.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). V. SKIN SENSITIZATION TO BAL.

Authors:  M B Sulzberger; R L Baer; A Kanof
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

4.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). II. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE.

Authors:  J Wexler; H Eagle; H J Tatum; H J Magnuson; E B Watson
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

  4 in total
  1 in total

1.  Dimercaprol is an acrolein scavenger that mitigates acrolein-mediated PC-12 cells toxicity and reduces acrolein in rat following spinal cord injury.

Authors:  Ran Tian; Riyi Shi
Journal:  J Neurochem       Date:  2017-05-03       Impact factor: 5.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.